Patents by Inventor Joe McCann

Joe McCann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20250127940
    Abstract: Radiopharmaceutical compositions with extended shelf life are provided, including radiopharmaceutical agents that include one or aryl-halide moieties and formulated with a gentisate compound.
    Type: Application
    Filed: November 1, 2024
    Publication date: April 24, 2025
    Inventors: Joe MCCANN, Mark DORNAN
  • Radiopharmaceutical and Methods
    Publication number: 20250057998
    Abstract: A radiopharmaceutical 177Lu-DOTATATE compound, a composition, and a kit are provided. Further provided are methods of synthesis of a 177Lu-DOTATATE compound and methods of treatment that comprise a 177Lu-DOTATATE compound.
    Type: Application
    Filed: August 28, 2024
    Publication date: February 20, 2025
    Inventors: Joe McCANN, Mark DORNAN
  • RADIOPHARMACEUTICAL TREATMENT METHODS AND USE
    Publication number: 20250025584
    Abstract: In one aspect, therapeutic use, methods of treatment and kits comprising 177Lu-PSMA I&T are provided for subjects exhibiting prostate cancer progression following administration with one or more androgen receptor inhibitor agents.
    Type: Application
    Filed: May 28, 2024
    Publication date: January 23, 2025
    Inventors: Neil FLESHNER, Jessica JENSEN, Joe MCCANN
  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20240108765
    Abstract: The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T.
    Type: Application
    Filed: April 17, 2023
    Publication date: April 4, 2024
    Inventor: Joe McCann
  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20230302163
    Abstract: The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T.
    Type: Application
    Filed: September 22, 2022
    Publication date: September 28, 2023
    Inventor: Joe McCann
  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20220387637
    Abstract: A radiopharmaceutical 177Lu-DOTATATE compound, a composition, and a kit are provided. Further provided are methods of synthesis of a 177Lu-DOTATATE compound and methods of treatment that comprise a 177Lu-DOTATATE compound.
    Type: Application
    Filed: August 4, 2022
    Publication date: December 8, 2022
    Inventors: Joe McCann, Justyna Kelly, Paul Billone
  • Radiopharmaceutical and methods
    Patent number: 11491246
    Abstract: The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T.
    Type: Grant
    Filed: July 13, 2021
    Date of Patent: November 8, 2022
    Assignee: POINT Biopharma, Inc.
    Inventor: Joe McCann
  • Radiopharmaceutical and methods
    Patent number: 11439714
    Abstract: A radiopharmaceutical 177Lu-DOTATATE compound, a composition, and a kit are provided. Further provided are methods of synthesis of a 177Lu-DOTATATE compound and methods of treatment that comprise a 177Lu-DOTATATE compound.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: September 13, 2022
    Assignee: Centre for Probe Development and Commercialization
    Inventors: Joe McCann, Justyna Kelly, Paul Billone
  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20220062447
    Abstract: A radiopharmaceutical 177Lu-DOTATATE compound, a composition, and a kit are provided. Further provided are methods of synthesis of a 177Lu-DOTATATE compound and methods of treatment that comprise a 177Lu-DOTATATE compound.
    Type: Application
    Filed: August 30, 2021
    Publication date: March 3, 2022
    Inventors: Joe McCann, Justyna Kelly, Paul Billone
  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20220016274
    Abstract: The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T.
    Type: Application
    Filed: September 27, 2021
    Publication date: January 20, 2022
    Inventor: Joe McCann
  • RADIOPHARMACEUTICAL AND METHODS
    Publication number: 20220008564
    Abstract: The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T.
    Type: Application
    Filed: July 13, 2021
    Publication date: January 13, 2022
    Inventor: Joe McCann
  • Radiopharmaceutical and methods
    Patent number: 11129912
    Abstract: The radiopharmaceutical 177Lu-PSMA I&T is provided, including in high purities with extended shelf life. Further provided are methods of synthesis of 177Lu-PSMA I&T and pharmaceutical compositions and methods of treatment that comprise 177Lu-PSMA I&T.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: September 28, 2021
    Assignee: POINT Biopharma Inc.
    Inventor: Joe McCann